Bulldog Bio, Fluxion Reach Distribution Deal for Flow Cell Instruments | GenomeWeb

NEW YORK (GenomeWeb News) – Bulldog Bio today said it will distribute Fluxion Biosciences' flow cell instruments to research laboratories in North America.

Under the terms of the announced deal, Bulldog will distribute Fluxion's BioFlux EZ and BioFlux 200 systems in the US and Canada. Financial and other terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.